These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7593712)

  • 1. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
    McSwain ML; Forman LM
    J Clin Psychopharmacol; 1995 Aug; 15(4):284. PubMed ID: 7593712
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse interaction of tacrine and haloperidol.
    Maany I
    Am J Psychiatry; 1996 Nov; 153(11):1504. PubMed ID: 8890692
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parkinsonian syndrome related to tacrine].
    Cabeza-Alvarez CI; González-Rubio M; García-Montero R; Alvarez-Tejerina A
    Neurologia; 1999 Feb; 14(2):96. PubMed ID: 10100429
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance to tacrine, arterial hypotension and leuko-araiosis in Alzheimer's disease.
    Lebert F; Mouly C; Pasquier F
    Age Ageing; 1998 Sep; 27(5):654. PubMed ID: 12675108
    [No Abstract]   [Full Text] [Related]  

  • 5. Convulsive effects of tacrine.
    Lebert F; Hasenbroekx C; Pasquier F; Petit H
    Lancet; 1996 May; 347(9011):1339-40. PubMed ID: 8622541
    [No Abstract]   [Full Text] [Related]  

  • 6. Levetiracetam-induced parkinsonism in a Huntington disease patient.
    Zesiewicz TA; Sanchez-Ramos J; Sullivan KL; Hauser RA
    Clin Neuropharmacol; 2005; 28(4):188-90. PubMed ID: 16062099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease.
    Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977
    [No Abstract]   [Full Text] [Related]  

  • 8. Selegiline for neuroleptic-induced parkinsonism.
    Gewirtz GR; Sharif Z; Cadet JL; Sarti P; Gorman JM
    Pharmacopsychiatry; 1993 Jul; 26(4):128-9. PubMed ID: 7901857
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrine: a second look. An outdated drug to be discarded.
    Prescrire Int; 1999 Feb; 8(39):16-8. PubMed ID: 10557569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic.
    Lyketsos CG; Corazzini K; Steele CD; Kraus MF
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):67-73. PubMed ID: 8845704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Piracetam, nimodipine and tacrine in the pharmacologic treatment of dementia: bibliographic review].
    Ojer Tsakiridu D; Dosantos Hernández JO; Larrabe Medina J; Sánchez Casado JI; Sologuren Echenagusia A
    Aten Primaria; 1996 Sep; 18(5):257-60, 262-4. PubMed ID: 8936720
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between olanzapine and haloperidol.
    Gomberg RF
    J Clin Psychopharmacol; 1999 Jun; 19(3):272-3. PubMed ID: 10350035
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacopsychiatry and iatrogenic parkinsonism].
    Pérez de Francisco C; Garnica Portillo R
    Neurol Neurocir Psiquiatr; 1978; 19(1):53-7. PubMed ID: 30054
    [No Abstract]   [Full Text] [Related]  

  • 15. Extrapyramidal symptoms from intravenous haloperidol in the treatment of delirium.
    Blitzstein SM; Brandt GT
    Am J Psychiatry; 1997 Oct; 154(10):1474-5. PubMed ID: 9326840
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ursodeoxycholic acid and prevention of tacrine-induced hepatotoxicity: a pilot study].
    Salmon L; Montet JC; Oddoze C; Montet AM; Portugal H; Michel BF
    Therapie; 2001; 56(1):29-34. PubMed ID: 11322014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tacrine].
    Dávila C; Viteri C; de Castro P
    Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse Lewy body disease: a common yet misdiagnosed dementia in which neuroleptics may be contraindicated.
    Scarbrough TJ
    Tenn Med; 1998 Feb; 91(2):58-60. PubMed ID: 9478123
    [No Abstract]   [Full Text] [Related]  

  • 19. Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.
    Schuster JP; Buhl C; Archambaud F; Hardy P; Chouinard G; Prigent A; Corruble E
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):206. PubMed ID: 17362445
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced dysphagia.
    Bulling M
    Aust N Z J Med; 1999 Oct; 29(5):748. PubMed ID: 10630662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.